Cox J - Search Results

1

Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada.

Palayew A, Schmidt AM, Saeed S, Cooper CL, Wong A, Martel-Laferrière V, Walmsley S, Cox J, Klein MB; Canadian Coinfection Cohort Study Investigators. Palayew A, et al. Among authors: cox j. PLoS One. 2021 Apr 19;16(4):e0249836. doi: 10.1371/journal.pone.0249836. eCollection 2021. PLoS One. 2021. PMID: 33872319 Free PMC article.

2

CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.

Klein MB, Cooper C, Brouillette MJ, Sheehan NL, Benkelfat C, Annable L, Weston F, Kraus D, Singer J; CTN194 Investigators. Klein MB, et al. Contemp Clin Trials. 2008 Jul;29(4):617-30. doi: 10.1016/j.cct.2008.01.001. Epub 2008 Jan 12. Contemp Clin Trials. 2008. PMID: 18262853 Clinical Trial.

3

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.

Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB; Canadian Co-infection Cohort Study Investigators. Potter M, et al. AIDS. 2010 Jul 31;24(12):1857-65. doi: 10.1097/QAD.0b013e32833adbb5. AIDS. 2010. PMID: 20479633

4

HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.

Klein MB, Rollet KC, Saeed S, Cox J, Potter M, Cohen J, Conway B, Cooper C, Côté P, Gill J, Haase D, Haider S, Hull M, Moodie E, Montaner J, Pick N, Rachlis A, Rouleau D, Sandre R, Tyndall M, Walmsley S; Canadian HIV-HCV Cohort Investigators. Klein MB, et al. Among authors: cox j. HIV Med. 2013 Jan;14(1):10-20. doi: 10.1111/j.1468-1293.2012.01028.x. Epub 2012 May 28. HIV Med. 2013. PMID: 22639840 Free article.

5

Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.

Cox J, Maurais E, Hu L, Moodie EE, Law S, Bozinoff N, Potter M, Rollet K, Hull M, Tyndall M, Cooper C, Gill J, Saeed S, Klein MB; Canadian Co-infection Cohort (CTN 222). Cox J, et al. Drug Alcohol Depend. 2014 Apr 1;137:121-8. doi: 10.1016/j.drugalcdep.2014.01.014. Epub 2014 Jan 30. Drug Alcohol Depend. 2014. PMID: 24559606

6

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.

Cooper C, Rollet-Kurhajec KC, Young J, Vasquez C, Tyndall M, Gill J, Pick N, Walmsley S, Klein MB; Canadian Co-infection Cohort Study Investigators. Cooper C, et al. HIV Med. 2015 Jan;16(1):24-31. doi: 10.1111/hiv.12168. Epub 2014 May 18. HIV Med. 2015. PMID: 24837567 Free PMC article.

7

Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study.

Young J, Potter M, Cox J, Cooper C, Gill J, Hull M, Walmsley S, Klein MB. Young J, et al. Among authors: cox j. CMAJ Open. 2013 Sep 24;1(3):E106-14. doi: 10.9778/cmajo.20130009. eCollection 2013 Sep. CMAJ Open. 2013. PMID: 25077109 Free PMC article.

8

Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.

Moqueet N, Infante-Rivard C, Platt RW, Young J, Cooper C, Hull M, Walmsley S, Klein MB; Canadian Co-Infection Study Investigators. Moqueet N, et al. Int J Mol Sci. 2015 Mar 20;16(3):6496-512. doi: 10.3390/ijms16036496. Int J Mol Sci. 2015. PMID: 25803108 Free PMC article.

9

Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.

Yeung MW, Young J, Moodie E, Rollet-Kurhajec KC, Schwartzman K, Greenaway C, Cooper C, Cox J, Gill J, Hull M, Walmsley S, Klein MB. Yeung MW, et al. Among authors: cox j. HIV Clin Trials. 2015 May-Jun;16(3):100-10. doi: 10.1179/501100000024. Epub 2015 May 14. HIV Clin Trials. 2015. PMID: 25972048

10

Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.

Rollet-Kurhajec KC, Moodie EE, Walmsley S, Cooper C, Pick N, Klein MB; Canadian Co-infection Cohort Study (CTN 222). Rollet-Kurhajec KC, et al. PLoS One. 2015 Jun 19;10(6):e0129868. doi: 10.1371/journal.pone.0129868. eCollection 2015. PLoS One. 2015. PMID: 26090666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,707 results

Search Page